{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:52:29Z","timestamp":1793267549662,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clinthera.2023.04.003","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T20:29:04Z","timestamp":1688502544000},"page":"562-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Self-reported Medicinal Cannabis Use as an Alternative to Prescription and Over-the-counter Medication Use Among US Military Veterans"],"prefix":"10.1016","volume":"45","author":[{"given":"Marion","family":"McNabb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2089-2256","authenticated-orcid":false,"given":"Katherine A.","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Trocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal","family":"MacCaffrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Brum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Mandile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.04.003_bib0001","series-title":"National Center for Veterans Analysis and Statistics [VA website]","year":"2022"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0002","unstructured":"US Department of Health and Human Services; Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey on Drug Use and Health: Veteran Adults. 2019. [SAMHSA website] Available at: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt31103\/2019NSDUH-Veteran\/Veterans%202019%20NSDUH.pdf. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0003","unstructured":"Disabled American Veterans. Learn More About PTSD in Veterans. 2022. Available at: https:\/\/www.dav.org\/Veterans\/resources\/post-traumatic-stress-disorder-ptsd. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0004","series-title":"National Veteran Suicide Prevention Annual Report [VA website]","year":"2022"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0005","unstructured":"Gunn D. Tracing the War on Terror\u2019s Impact on Opioid Abuse [National Bureau of Economic Research, The Digest online]. 2020. Available at: https:\/\/www.nber.org\/digest\/jan20\/tracing-war-terrors-impact-opioid-abuse. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0006","first-page":"6","article-title":"The 2019 Veterans Health and Medical Cannabis Study","volume":"1","author":"McNabb","year":"2020","journal-title":"Cannabis Science and Technology"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0007","unstructured":"Fertig N. VA Rejects Cannabis Research As Veterans Plead for Medical Pot [Politico online]. 2021. Available at: https:\/\/www.politico.com\/news\/2021\/11\/08\/va-reject-medical-marijuana-Veterans-519757. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0008","unstructured":"National Conference of State Legislatures (NCSL). State Medical Cannabis Laws. 2022. [NCSL website] Available at: https:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx#:~:text=MEDICAL%2DUSE%20UPDATE%3A%20As%20of,medical%20use%20of%20cannabis%20products. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0009","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","year":"2017"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0010","doi-asserted-by":"crossref","unstructured":"O\u2019Grady. Cannabis Research Database Shows How U.S. Funding Focuses on Harms of the Drug [Science online]. 2020. Available at: https:\/\/www.science.org\/content\/article\/cannabis-research-database-shows-how-us-funding-focuses-harms-drug. Accessed March 24, 2023.","DOI":"10.1126\/science.abe5328"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0011","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.3390\/ijms21124448","article-title":"Cannabis, the endocannabinoid system and immunity\u2014the journey from the bedside to the bench and back","volume":"21","author":"Almogi-Hazan","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0012","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/biomedicines10030539","article-title":"Neurological benefits, clinical challenges, and neuropathologic promise of medical marijuana: a systematic review of cannabinoid effects in multiple sclerosis and experimental models of demyelination","volume":"10","author":"Longoria","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0013","first-page":"e3278","article-title":"Epilepsy and cannabis: a literature review","volume":"10","author":"Zaheer","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0014","unstructured":"US Food and Drug Administration (FDA). FDA Approves First Drug Comprised of an Active Ingredient Derived From Marijuana to Treat Rare, Severe Forms of Epilepsy. 2018. [FDA News online] Available at: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0015","first-page":"668","article-title":"Therapeutic use of cannabis in inflammatory bowel disease","volume":"12","author":"Ahmed","year":"2016","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0016","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1200\/OP.22.00080","article-title":"Cannabis use in patients with cancer: a clinical review","volume":"18","author":"Worster","year":"2022","journal-title":"JCO Oncology Practice"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0017","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/1527154421989609","article-title":"Medicinal cannabis: policy, patients, and providers","volume":"22","author":"Ryan","year":"2021","journal-title":"Policy, Politics, & Nursing Practice"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0018","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1007\/s00520-021-06301-x","article-title":"A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction","volume":"29","author":"Zylla","year":"2021","journal-title":"Supportive Care in Cancer"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0019","doi-asserted-by":"crossref","first-page":"E694","DOI":"10.1503\/cmaj.091414","article-title":"Smoked cannabis for chronic neuropathic pain: a randomized controlled trial","volume":"182","author":"Ware","year":"2010","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000515069","article-title":"A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019","volume":"4","author":"Jugl","year":"2021","journal-title":"Medical Cannabis and Cannabinoids"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpr.2016.10.002","article-title":"Medical cannabis and mental health: a guided systematic review","volume":"51","author":"Walsh","year":"2017","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0022","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/medicina55090525","article-title":"Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): a systematic review","volume":"55","author":"Orsolini","year":"2019","journal-title":"Medicina"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0023","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3934\/Neuroscience.2021022","article-title":"Cannabis in the management of PTSD: a systematic review","volume":"8","author":"Rehman","year":"2021","journal-title":"AIMS Neuroscience"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0024","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/can.2020.0056","article-title":"The long-term, prospective, therapeutic impact of cannabis on post-traumatic stress disorder","volume":"7","author":"Bonn-Miller","year":"2022","journal-title":"Cannabis and Cannabinoid Research"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0025","unstructured":"Stoner S.A. Effects of Marijuana on Mental Health: Anxiety Disorders [University of Washington Alcohol & Drug Abuse Institute website]. 2017. Available at: https:\/\/adai.uw.edu\/pubs\/pdf\/2017mjanxiety.pdf. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.729800","article-title":"Antidepressant and anxiolytic effects of medicinal cannabis use in an observational trial","volume":"12","author":"Martin","year":"2021","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2021.106991","article-title":"Cannabis and mental health: prevalence of use and modes of cannabis administration by mental health status","volume":"121","author":"Rup","year":"2021","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0028","unstructured":"Compassionate Clinics of America (CCA). Harm Reduction: Learn Why People With Substance Use Disorder Are Using Cannabis. 2022. [CCA website] Available at: https:\/\/mycompassionateclinic.com\/medical-cannabis-as-harm-reduction. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0029","series-title":"Cannabis Public Policy Consulting. Examination of Experiences, Behaviors, and Outcomes of Medical Cannabis Patients and Providers in New Mexico","year":"2022"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0030","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2105\/AJPH.2021.306168","article-title":"Use of cannabis for harm reduction among people at high risk for overdose in Vancouver, Canada (2016-2018)","volume":"111","author":"Mok","year":"2021","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0031","first-page":"14","article-title":"Rationale for cannabis-based interventions in the opioid overdose crisis","author":"Lucas","year":"2017","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0032","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/dar.12275","article-title":"A safer alternative: cannabis substitution as harm reduction","volume":"34","author":"Lau","year":"2015","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0033","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-021-00520-5","article-title":"Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample","volume":"18","author":"Kvamme","year":"2021","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0034","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/can.2018.0022","article-title":"Emerging evidence for cannabis' role in opioid use disorder","volume":"3","author":"Wiese","year":"2018","journal-title":"Cannabis and Cannabinoid Research"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0035","first-page":"374","article-title":"Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline","author":"Busse","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0036","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0037","doi-asserted-by":"crossref","DOI":"10.1186\/s40621-019-0213-z","article-title":"State marijuana laws and opioid overdose mortality","volume":"6","author":"Chihuri","year":"2019","journal-title":"Injury Epidemiology"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0038","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hec.4237","article-title":"The impact of medical and recreational marijuana laws on opioid prescribing in employer-sponsored health insurance","volume":"30","author":"Wen","year":"2021","journal-title":"Health Economics"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0039","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09540261.2018.1509842","article-title":"What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review","volume":"30","author":"Campbell","year":"2018","journal-title":"International Review of Psychiatry"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0040","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/00952990.2019.1604722","article-title":"A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis","volume":"45","author":"Loflin","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0041","unstructured":"Veterans of Foreign Wars (VFW). Federal Study Finds Cannabis Beneficial for PTSD Treatment. 2021. [VFW website] Available at: https:\/\/www.vfw.org\/media-and-events\/latest-releases\/archives\/2021\/9\/federal-study-finds-cannabis-beneficial-for-ptsd-treatment. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0042","first-page":"1","article-title":"Weeding out the stigma: Older veterans in Illinois share their experiences using medical cannabis","author":"Clary","year":"2022","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0043","first-page":"120","article-title":"Prevalence of cannabis use, disorder, and medical card possession in U.S. military veterans: Results from the 2019\u20132020 National Health and Resilience in Veterans Study","author":"Hill","year":"2021","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0044","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1037\/tps0000133","article-title":"Medicinal versus recreational cannabis use among returning veterans","volume":"4","author":"Metrik","year":"2018","journal-title":"Translational Issues in Psychological Science"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0045","unstructured":"South T. FDA-Regulated Study Shows Promise for Using Marijuana To Treat Veterans with PTSD [Military Times online]. 2021. Available at https:\/\/www.militarytimes.com\/news\/your-military\/2021\/03\/19\/fda-regulated-study-shows-promise-for-using-marijuana-to-treat-veterans-with-ptsd\/#:%E2%88%BC:text=in%20new%20window)-,FDA%2Dregulated%20study%20shows%20promise%20for%20using,to%20treat%20veterans%20with%20PTSD&text=The%20first%20FDA%2Dregulated%2C%20placebo,component%20in%20the%20herbal%20drug. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246990","article-title":"The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: a randomized cross-over clinical trial","volume":"16","author":"Bonn-Miller","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2021.101958","article-title":"Cannabis use among military veterans: a great deal to gain or lose?","volume":"84","author":"Turna","year":"2021","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0048","unstructured":"Disabled American Veterans (DAV). Medical Cannabis as an alternative to opioids for veterans [DAV website]. Available at: https:\/\/www.dav.org\/Veterans\/resources\/medical-cannabis. Accessed September 28, 2022."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0049","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12888-023-04648-5","article-title":"A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care","volume":"23","author":"Zaman","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0050","series-title":"Access to VHA Clinical Programs for Veterans Participating in State-Approved Marijuana Programs","year":"2020"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0051","unstructured":"US Department of Veterans Affairs (VA). VA and Marijuana\u2014What Veterans Needs To Know. 2022. Available at: https:\/\/www.publichealth.va.gov\/marijuana.asp#:~:text=VA%20will%20not%20pay%20for,medical%20centers%2C%20locations%20and%20grounds. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0052","unstructured":"Massachusetts Fallen Heros (MFH). Curaleaf to launch veterans cannabis project initiative in Massachusetts at Hanover Medical Dispensary (MFH website). 2020. Available at: https:\/\/www.massfallenheroes.org\/curaleaf-to-launch-Veterans-cannabis-project-initiative-in-massachusetts-at-hanover-medical-dispensary. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0053","unstructured":"Hasse J. This Company Is Offering Cannabis for U.S. Military Veterans at a 30% to 50% Discount. 2019. [Forbes online] Available at https:\/\/www.forbes.com\/sites\/javierhasse\/2019\/08\/28\/cheap-cannabis-for-Veterans\/?sh=13a91a21397. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0054","unstructured":"Long Z., Eanet L. Where To Buy Legal Weed in Chicago. 2023. [Time Out Chicago online] Available at: https:\/\/www.timeout.com\/chicago\/shopping\/best-chicago-dispensaries-for-weed. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0055","unstructured":"Enright M., Chiwaya N., Muccari R. \u201cRidiculous\u201d Price of Medical Marijuana Leaves Patients Scrambling. 2021. [NBC News online] Available at: https:\/\/www.nbcnews.com\/news\/us-news\/ridiculous-price-medical-marijuana-leaves-patients-scrambling-n1274085. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0056","series-title":"Vietnam Veterans\u2019 Income in Retirement","year":"2020"},{"key":"10.1016\/j.clinthera.2023.04.003_bib0057","unstructured":"Piatek, C. State of Michigan Awards U-M Researchers $7.4 Million To Study Effect of CBD and Medical Cannabis Therapy on Veterans\u2019 Chronic Pain [Precision Health University of Michigan website]. 2022. Available at: https:\/\/medicine.umich.edu\/dept\/anesthesiology\/news\/archive\/202209\/state-michigan-awards-u-m-researchers-74-million-study-effect-cbd-medical-cannabis-therapy-Veterans%E2%80%99. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0058","unstructured":"Illinois Department of Public Health (ILDOH). Medical Cannabis Patient Registry Program. 2022. [ILDOH website] Available at: https:\/\/dph.illinois.gov\/topics-services\/prevention-wellness\/medical-cannabis.html. Accessed March 24, 2023."},{"key":"10.1016\/j.clinthera.2023.04.003_bib0059","unstructured":"California Senate Bill No. 34, Chapter 837. 2019. An act to amend Sections 26001, 26153, 26161, and 26162.5 of, and to add Section 26071 to, the Business and Professions Code, and to amend Sections 34010, 34011, and 34012 of, and to add and repeal Sections 6414 and 34012.1 of, the Revenue and Taxation Code, relating to cannabis. Approved by Governor October 12, 2019. Filed with Secretary of State on October 12, 2019. Available at: https:\/\/leginfo.legislature.ca.gov\/faces\/billTextClient.xhtml?bill_id=201920200SB34. Accessed March 24, 2023."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823001339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823001339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:58:42Z","timestamp":1758963522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823001339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0149291823001339"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.04.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-reported Medicinal Cannabis Use as an Alternative to Prescription and Over-the-counter Medication Use Among US Military Veterans","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}